Jubilant Life Sciences Ltd said it received approval for its Telmisartan Tablets used to treat hypetension or high blood pressure.
The approval was given under an abbreviated new drug application, which is used by the US Food and Drug administration for giving permission to generic drugs in the country.
Telmisartan Tablets are the generic version of Micardis Tablets of Boehringer Ingelheim Pharmaceuticals Inc.
The market size for the new tablet was not available.
Out of 770 filings for Oral Solids Jubilant Life Sciences received 578 approvals in various regions globally as on June 30, 2016. This includes 70 drug applications filed in the US, of which 44 have been approved and 104 filings in Europe.
Jubilant Life Sciences Limited is an integrated global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of active pharmaceutical ingredients, solid dosage formulations, radio pharmaceuticals, allergy therapy products and life science ingredients.
Jubilant Life Sciences also provides Services in Contract Manufacturing of Sterile Products and Drug Discovery Solutions.
The company has 11 facilities in India, US and Canada and a team of about 6,200 people across the globe, with customer reach over 100 countries .